12 May 2025 Date | | - Cons. EPS | - EPS |
24 Mar 2025 Date | | - Cons. EPS | - EPS |
4 Nov 2024 Date | | - Cons. EPS | - EPS |
30 Oct 2024 Date | | - Cons. EPS | - EPS |
8 Aug 2024 Date | | - Cons. EPS | - EPS |
12 May 2025 Date | | - Cons. EPS | - EPS |
24 Mar 2025 Date | | - Cons. EPS | - EPS |
4 Nov 2024 Date | | - Cons. EPS | - EPS |
30 Oct 2024 Date | | - Cons. EPS | - EPS |
8 Aug 2024 Date | | - Cons. EPS | - EPS |
Medical Devices Industry | Healthcare Sector | Mr. William Charles Hayde CEO | OTCQB Exchange | US67021R1041 ISIN |
US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Nu-Med Plus, Inc. is a pioneering medical device company with a focus on the design, development, enhancement, and commercialization of innovative medical devices on a global scale. Since its establishment in 2011, the company has positioned itself as a key player in the medical device industry, offering solutions that aim at improving patient outcomes and supporting the medical community. Nu-Med Plus specializes in the delivery systems for nitric oxide, a critical medical gas used in various therapeutic and research applications. Headquartered in New York, New York, the company serves a wide range of clients including hospitals, health systems, and medical professionals, striving to contribute to the advancement of healthcare technologies and treatments.
This system is specifically designed for use in hospital settings, enabling the controlled delivery of nitric oxide gas for therapeutic applications. It's engineered to meet the rigorous demands of the healthcare environment, providing a reliable solution for the management of conditions where nitric oxide therapy is indicated.
Geared towards clinical settings, this delivery system facilitates the administration of nitric oxide for various clinical applications. It combines ease of use with precision, offering healthcare providers a dependable tool for the delivery of nitric oxide in a controlled manner.
This innovative device is a portable, rechargeable solution for the delivery of nitric oxide gas on-the-go. Designed for mobility, it supports out-of-hospital care scenarios, including home care or remote medical services, ensuring patients receive timely and effective nitric oxide therapy wherever they are.
Nu-Med Plus also offers a nitric oxide system tailored for research purposes. This system is ideal for academic, pharmaceutical, and medical research communities, providing a scalable and precise means to utilize nitric oxide gas in experimental and study settings.